title: Gamma globulin re-treatment in Kawasaki disease.
abstract: We retrospectively reviewed the effects of intravenous gamma-globulin (IVGG) re-treatment of 13 children with Kawasaki disease and persistent or recrudescent fever. Fever and mucocutaneous inflammation resolved within 48 hours in nine patients; fever abated in two other children after a third course of IVGG. We conclude that IVGG re-treatment of Kawasaki disease appears to be safe and may improve the clinical course.
authors.affiliation: Department of Medicine, Children's Hospital, Boston, Massachusetts 02115.
authors.forename: R P
authors.initials: RP
authors.lastname: Sundel
authors.forename: J C
authors.initials: JC
authors.lastname: Burns
authors.forename: A
authors.initials: A
authors.lastname: Baker
authors.forename: A S
authors.initials: AS
authors.lastname: Beiser
authors.forename: J W
authors.initials: JW
authors.lastname: Newburger
mesh_terms: D002675:Child, Preschool; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000453:epidemiology / Q000628:therapy*; D012189:Retrospective Studies; D017211:Treatment Failure
chemical_list: D016756:Immunoglobulins, Intravenous